|
|
|
|
1 | (6) |
|
|
7 | (2) |
|
|
|
|
9 | (3) |
|
|
10 | (1) |
|
|
10 | (1) |
|
|
10 | (1) |
|
|
10 | (1) |
|
|
11 | (1) |
|
|
11 | (1) |
|
|
11 | (1) |
|
|
11 | (1) |
|
|
11 | (1) |
|
|
11 | (1) |
|
|
11 | (1) |
|
|
12 | (1) |
|
Comparing Mycoplasma, CWD Forms, and Rickettsia |
|
|
|
|
13 | (1) |
|
Similarities Relating Mycoplasma and CWD Forms |
|
|
13 | (2) |
|
|
13 | (1) |
|
Atmosphere Optimum for Growth |
|
|
14 | (1) |
|
|
14 | (1) |
|
|
14 | (1) |
|
|
15 | (1) |
|
|
15 | (1) |
|
|
15 | (1) |
|
Biochemical Properties Shared |
|
|
15 | (1) |
|
Factors Distinguishing Mycoplasma from CWD Forms |
|
|
15 | (3) |
|
|
15 | (1) |
|
|
15 | (1) |
|
Sensitivity to Penicillin |
|
|
15 | (1) |
|
|
16 | (1) |
|
|
17 | (1) |
|
Bacteriocin Susceptibility |
|
|
17 | (1) |
|
Wall-Associated Structures |
|
|
18 | (1) |
|
|
18 | (1) |
|
|
18 | (1) |
|
|
19 | (2) |
|
Propeties and Peculiarities |
|
|
|
|
21 | (1) |
|
|
21 | (1) |
|
|
22 | (1) |
|
Variation in Development of Units |
|
|
23 | (1) |
|
|
24 | (1) |
|
|
24 | (1) |
|
Substrate and Morphology: Order from Chaos |
|
|
24 | (1) |
|
|
24 | (1) |
|
Carbohydrates Influence Morphology |
|
|
24 | (1) |
|
|
25 | (1) |
|
|
25 | (1) |
|
Growth at Varying Depths in Agar |
|
|
25 | (1) |
|
Peculiarities in Corynebacterium diphtheria Colonies |
|
|
25 | (1) |
|
Variation in CWD Colonies, Including Rough and Smooth |
|
|
25 | (1) |
|
|
26 | (1) |
|
|
26 | (1) |
|
|
26 | (1) |
|
Luminescence and Fluorescence |
|
|
27 | (1) |
|
Inhibition by Classical Bacteria |
|
|
27 | (1) |
|
|
28 | (1) |
|
|
28 | (1) |
|
Resistance of CWD Forms to Physical Factors |
|
|
29 | (1) |
|
|
30 | (1) |
|
Are All Wall Deficient Variants of a Strain Identical? |
|
|
31 | (1) |
|
L-Forms as Plasmid Recipients |
|
|
31 | (1) |
|
|
31 | (1) |
|
Role of CWD Forms in Nutrition of Amoeba |
|
|
31 | (1) |
|
Why are Some Strains Highly Susceptible to CWD Form Induction? |
|
|
31 | (1) |
|
|
32 | (1) |
|
|
32 | (5) |
|
Composition of Cell Wall Deficient Forms |
|
|
|
|
37 | (2) |
|
Loss of Murein Components |
|
|
37 | (1) |
|
Substitutes for the Rigid Murein Layer |
|
|
37 | (1) |
|
Retention of Murein Components |
|
|
37 | (1) |
|
|
37 | (1) |
|
|
38 | (1) |
|
|
38 | (1) |
|
Loss of Polysaccharides and Protein |
|
|
39 | (1) |
|
|
39 | (1) |
|
|
39 | (1) |
|
Cholesterol in the Membrane |
|
|
39 | (1) |
|
Membrane Protein in L-Form |
|
|
40 | (1) |
|
|
40 | (2) |
|
Lipopolysaccharides and Lipids |
|
|
40 | (1) |
|
Composition Changes with Salts in Menstruum |
|
|
41 | (1) |
|
|
41 | (1) |
|
Group-Specific Polysaccharides |
|
|
41 | (1) |
|
|
41 | (1) |
|
|
42 | (1) |
|
|
42 | (1) |
|
|
42 | (1) |
|
|
42 | (1) |
|
DNA of Spore Spheroplasts |
|
|
42 | (1) |
|
|
43 | (1) |
|
|
43 | (4) |
|
Disclosures by Electron Microscopy |
|
|
|
|
47 | (1) |
|
A Close-Up View of the Wall |
|
|
47 | (3) |
|
|
47 | (2) |
|
|
49 | (1) |
|
|
50 | (1) |
|
|
50 | (1) |
|
Changes in the Cytoplasmic Membrane |
|
|
51 | (1) |
|
|
51 | (1) |
|
Excursions of the Cytoplasmic Membrane |
|
|
51 | (1) |
|
|
51 | (1) |
|
Vacuoles between Wall and Membrane |
|
|
51 | (1) |
|
|
52 | (1) |
|
Identifying-Structures and Antigens in Electron Micrographs |
|
|
52 | (1) |
|
Microtubules in Group D Streptococci |
|
|
52 | (1) |
|
Inclusions in Clostridium botulinum L-Forms |
|
|
52 | (1) |
|
Ferritin-Labeled Antibody |
|
|
53 | (1) |
|
Do All Variants Survive Fixation for Electron Microscopy? |
|
|
53 | (1) |
|
|
53 | (1) |
|
Scanning Beam Electron Microscope Studies |
|
|
54 | (1) |
|
|
55 | (1) |
|
|
55 | (4) |
|
Public Health and Nosocomial Facets |
|
|
|
Salmonella and Shigella Carriers |
|
|
59 | (1) |
|
L-Forms in the Clinical Laboratory |
|
|
59 | (1) |
|
CWD Forms in Water Supplies |
|
|
59 | (1) |
|
Wall Deficient Bacteria in Foods |
|
|
59 | (4) |
|
|
59 | (1) |
|
|
59 | (3) |
|
|
62 | (1) |
|
|
62 | (1) |
|
CWD Bacteria in Diseases of Vegetables |
|
|
62 | (1) |
|
Nosocomial Acquisition of Chlamydia |
|
|
63 | (1) |
|
``Sterile'' Water in Hospitals |
|
|
63 | (2) |
|
Pseudomonas aeruginosa Contamination |
|
|
63 | (2) |
|
Significant Factors in Successful Contamination with P. aeruginosa |
|
|
65 | (1) |
|
Detecting the Pseudomonas Variants |
|
|
65 | (1) |
|
|
65 | (1) |
|
|
65 | (1) |
|
Sterilization of Instruments |
|
|
66 | (1) |
|
Possibility of CWD Stages in Toxoid |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
66 | (1) |
|
|
67 | (2) |
|
|
|
Detection of Typhoid Cases and Carriers by Their Spheroplast Antibody or Antigenemia |
|
|
69 | (1) |
|
Wall Deficient Forms as Vaccines |
|
|
69 | (1) |
|
Spheroplast Production by Lysozyme without Antibody |
|
|
70 | (1) |
|
Spheroplasts in Identification of Pasteurella multocida Subtypes |
|
|
70 | (1) |
|
Antibody-Complement in Induction of Variants |
|
|
70 | (1) |
|
Spheroplasting by Leukocyte Products or Growth within Phagocytic Cells |
|
|
71 | (1) |
|
Mycobacteria and Leukocyte Products |
|
|
71 | (1) |
|
|
72 | (1) |
|
Antigens Unique to the CWD Variants |
|
|
72 | (1) |
|
Antigens Retained by CWD Variants |
|
|
72 | (1) |
|
Tissue Damage from CWD Antigens |
|
|
73 | (1) |
|
Antigens Missing or Minimized in the CWD Stage |
|
|
73 | (1) |
|
Interferon Production in Chicks |
|
|
73 | (1) |
|
|
73 | (1) |
|
Activation of the HIV Terminal Repeat |
|
|
73 | (1) |
|
|
73 | (1) |
|
|
74 | (1) |
|
Depression or Stimulation of the Major Immune Branches |
|
|
74 | (1) |
|
|
74 | (1) |
|
Increase in Exudate Cells |
|
|
74 | (1) |
|
Immortalizing Human Lymphocytes |
|
|
74 | (1) |
|
Loss of Immunity in Burned Tissue |
|
|
74 | (1) |
|
|
75 | (1) |
|
|
75 | (4) |
|
Induction by Antibiotics, Organic Compounds, and Miscellaneous Factors |
|
|
|
Mechanisms that Result in Cell Wall Deficiency |
|
|
79 | (1) |
|
Induction of CWD Forms by Antibiotics In Vitro |
|
|
79 | (3) |
|
|
80 | (1) |
|
Penicillin Induction as a Tool in Identifying a Classical Bacterium |
|
|
80 | (2) |
|
Formation of Wall Deficient Variants vs. Bacterial Death |
|
|
82 | (1) |
|
Relative Inducing Ability of Antibiotics |
|
|
82 | (2) |
|
|
83 | (1) |
|
|
83 | (1) |
|
|
83 | (1) |
|
|
83 | (1) |
|
Nystatin and Amphotericin B |
|
|
83 | (1) |
|
Snail Juice Induces Cell Wall Deficiency |
|
|
83 | (1) |
|
Dyes as Agents which Promote Cell Wall Deficiency of Microorganisms |
|
|
84 | (1) |
|
Effects of Pretreatments on Susceptibility to Induction |
|
|
84 | (1) |
|
Result of Numerous Transfers In Vitro |
|
|
84 | (1) |
|
In Vivo Induction of Cell Wall Deficient Microbes |
|
|
85 | (1) |
|
|
85 | (2) |
|
|
87 | (4) |
|
|
|
To Revert or Not to Revert? |
|
|
91 | (1) |
|
In Vitro Reversion Techniques |
|
|
92 | (4) |
|
Omission of the Inducing Agent |
|
|
92 | (1) |
|
Exposure to an Antibiotic |
|
|
93 | (1) |
|
|
93 | (1) |
|
Role of Serum, Yeast, and Vitamins |
|
|
93 | (1) |
|
|
93 | (1) |
|
|
93 | (1) |
|
Exclusion of All Large Molecules |
|
|
93 | (1) |
|
|
94 | (1) |
|
Support by Firm Agar or Gelatin |
|
|
94 | (1) |
|
Support by Cellulose Filter Pads |
|
|
94 | (1) |
|
|
94 | (1) |
|
|
95 | (1) |
|
Alternation of Culture Menstrua |
|
|
95 | (1) |
|
|
95 | (1) |
|
Reversion Stimulated by Products from Microbes |
|
|
95 | (1) |
|
|
95 | (1) |
|
|
96 | (1) |
|
Aging with or without Transfers |
|
|
96 | (1) |
|
|
96 | (1) |
|
|
96 | (1) |
|
Stablizing Induced L-Forms |
|
|
96 | (1) |
|
Characteristics of Revertants |
|
|
97 | (1) |
|
|
97 | (3) |
|
Inhibition of Reversion of Yeast Protoplasts by 2-Deoxyglucose |
|
|
97 | (1) |
|
|
97 | (1) |
|
Destroying the Reversion Inhibitor |
|
|
97 | (3) |
|
Morphology of the Reverting Organism |
|
|
100 | (1) |
|
|
100 | (1) |
|
|
100 | (1) |
|
|
100 | (1) |
|
|
100 | (1) |
|
|
101 | (4) |
|
Septicemia and Cardiopathies |
|
|
|
|
105 | (6) |
|
Subacute Bacterial Endocarditis |
|
|
105 | (1) |
|
SBE with CWD Propionibacterium |
|
|
105 | (3) |
|
Endocarditis Due to CWD Pseudomonas |
|
|
108 | (1) |
|
|
108 | (1) |
|
Administration of Antibiotic before Taking Blood Cultures |
|
|
109 | (1) |
|
Following Administration of an Antibiotic Inhibitory to the Classical Pathogen |
|
|
110 | (1) |
|
Infections Following Insertion of Prosthetic Cardiac Valves |
|
|
110 | (1) |
|
Nutritionally Variant Streptococci |
|
|
110 | (1) |
|
|
111 | (1) |
|
Myocarditis and Combined Myocarditis and Endocarditis |
|
|
112 | (1) |
|
|
112 | (1) |
|
Where Positive ``Negative'' Cultures can be Found |
|
|
112 | (1) |
|
Skip Cultures in Septicemia |
|
|
112 | (1) |
|
Allergy and Other Conditions Associated with CWD Bacteremia |
|
|
113 | (1) |
|
|
113 | (1) |
|
|
113 | (4) |
|
Intracellular Growth of CWD Forms |
|
|
|
Intraerythrocytic Cell Wall Deficient Forms |
|
|
117 | (3) |
|
Erythrocyte Parasitism Associated with Disease |
|
|
117 | (2) |
|
Postulations Concerning Auto-Immune Disease |
|
|
119 | (1) |
|
The Most Hypnotic of all Intraerythrocytic Forms |
|
|
119 | (1) |
|
CWD Forms within Platelets |
|
|
120 | (1) |
|
CWD Forms in Circulating Leukocytes |
|
|
120 | (2) |
|
Intracellular Growth of CWD Forms in Host Tissue |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
123 | (1) |
|
Intracellular Growth of CWD Forms in Tissue Culture |
|
|
123 | (1) |
|
Changes in the Microbial Variant in the Tissue Culture Cells |
|
|
123 | (1) |
|
CWD-Induction by Inoculation of Classical Bacteria into Tissue Culture |
|
|
124 | (1) |
|
Salmonella typhi in Tissue Culture |
|
|
124 | (1) |
|
L-Forms in Tissue Culture Cells |
|
|
124 | (1) |
|
CWD Forms as Tissue Culture Contaminants |
|
|
124 | (1) |
|
Growth of Bacteria within Fungi |
|
|
124 | (1) |
|
|
125 | (1) |
|
|
125 | (4) |
|
|
|
L-Forms in Surgery and Contraception |
|
|
129 | (1) |
|
Chlamydia in Coronary Thrombosis |
|
|
129 | (2) |
|
|
131 | (1) |
|
|
131 | (2) |
|
Urinary Tract Infections: Idiopathic Hematuria, Interstitial Cystitis, and Others |
|
|
|
|
133 | (6) |
|
Chronic Pyelonephritis as a Disease with Occult Organisms |
|
|
133 | (1) |
|
Treated and Untreated Cases Show Variants |
|
|
133 | (1) |
|
|
134 | (1) |
|
|
134 | (3) |
|
|
137 | (1) |
|
Systemic Lupus Erythermatosis |
|
|
137 | (1) |
|
|
137 | (1) |
|
|
138 | (1) |
|
|
138 | (1) |
|
|
138 | (1) |
|
|
139 | (1) |
|
Formation of Spheroplasts in the Rat and Mouse Kidney |
|
|
139 | (1) |
|
|
139 | (1) |
|
Glomerulonephritis in Guinea Pigs |
|
|
139 | (1) |
|
Kidney Medulla as a Protective Environment |
|
|
139 | (1) |
|
|
139 | (1) |
|
Negating the Protective Hypertonicity of the Medulla |
|
|
139 | (1) |
|
The Kidney as a Site Fostering Reversion |
|
|
140 | (1) |
|
Low Urine Glucose and Latent Infection |
|
|
140 | (2) |
|
|
140 | (2) |
|
|
142 | (1) |
|
CWD Bacteria as Normal Flora in Urine |
|
|
142 | (1) |
|
|
142 | (1) |
|
|
143 | (4) |
|
Listeria monocytogenes Studies |
|
|
|
|
147 | (1) |
|
|
147 | (1) |
|
|
147 | (2) |
|
Laboratory Studies on Wall Deficient Variants |
|
|
149 | (1) |
|
|
149 | (1) |
|
Listeria in Foods and Hospital Tubing |
|
|
149 | (1) |
|
Pathogenicity of Wall Deficient Variants |
|
|
150 | (1) |
|
Epidemiology of Listeria in Man |
|
|
150 | (1) |
|
|
151 | (1) |
|
Sensitivity to Bacteriophage |
|
|
151 | (1) |
|
|
151 | (1) |
|
|
151 | (4) |
|
|
|
|
155 | (3) |
|
|
155 | (1) |
|
|
155 | (1) |
|
|
156 | (1) |
|
|
156 | (1) |
|
Erysipelothrix rhusiopathiae |
|
|
157 | (1) |
|
|
157 | (1) |
|
Glasser's Disease of Swine |
|
|
157 | (1) |
|
|
157 | (1) |
|
|
157 | (1) |
|
|
157 | (1) |
|
|
158 | (1) |
|
Microbial Persistence Related to Intracellular Survival of CWD Forms |
|
|
158 | (1) |
|
|
159 | (1) |
|
|
159 | (1) |
|
|
159 | (4) |
|
Meningitis and Associated Conditions |
|
|
|
|
163 | (1) |
|
|
163 | (1) |
|
Species Wall Deficient in Meningitis |
|
|
163 | (2) |
|
|
164 | (1) |
|
|
164 | (1) |
|
|
164 | (1) |
|
|
165 | (1) |
|
|
165 | (1) |
|
|
165 | (1) |
|
Postoperative Infections in the Brain |
|
|
165 | (1) |
|
|
166 | (1) |
|
|
166 | (3) |
|
Rheumatic Fever and Erysipelas |
|
|
|
|
169 | (1) |
|
Role of Persisting Cocci and CWD Variants in Antibody Stimulation |
|
|
169 | (4) |
|
Pertinent Organisms in Circulating Blood |
|
|
169 | (1) |
|
|
170 | (1) |
|
CWD Streptococci in Cardiac Tissues |
|
|
170 | (2) |
|
Variants in Synovial Fluids of Rheumatic Fever Patients |
|
|
172 | (1) |
|
Erysipelas and Recurrent Erysipelas |
|
|
173 | (1) |
|
|
174 | (1) |
|
|
174 | (3) |
|
|
|
|
177 | (1) |
|
Recurrent Staphylococcal Osteomyelitis |
|
|
177 | (1) |
|
Chronic Staphylococcal Osteomyelitis |
|
|
177 | (1) |
|
Streptococcal Osteomyelitis |
|
|
177 | (1) |
|
|
178 | (1) |
|
|
178 | (1) |
|
|
178 | (1) |
|
|
178 | (2) |
|
|
178 | (1) |
|
|
179 | (1) |
|
|
179 | (1) |
|
|
179 | (1) |
|
Septic Arthritis in Children |
|
|
179 | (1) |
|
Hemophilus influenzae in Arthritis |
|
|
180 | (1) |
|
|
180 | (1) |
|
Nocardia asteroides in Canine Arthritis |
|
|
180 | (1) |
|
|
180 | (1) |
|
|
180 | (4) |
|
Are Classical Streptococci Involved? |
|
|
180 | (1) |
|
Listeria-Like CWD Forms in Blood |
|
|
180 | (1) |
|
|
181 | (1) |
|
The Virus in Rheumatoid Arthritis |
|
|
181 | (1) |
|
Role of CWD Propionibacterium acnes in Rheumatoid Arthritis |
|
|
182 | (1) |
|
Resume Rheumatoid Arthritis |
|
|
183 | (1) |
|
Juvenile Rheumatoid Arthritis |
|
|
184 | (1) |
|
|
184 | (1) |
|
Findings in Veterinary Medicine |
|
|
184 | (1) |
|
Subcutaneous Abscesses with Arthritis |
|
|
184 | (1) |
|
|
185 | (1) |
|
|
186 | (3) |
|
Mycobacterium tuberculosis and the Atypicals |
|
|
|
|
189 | (1) |
|
In Vitro Growth of CWD Mycobacteria |
|
|
189 | (1) |
|
Spontaneous Variant Growth in Plants |
|
|
190 | (1) |
|
Wall Deficient Mycobacterium tuberculosis in Blood |
|
|
191 | (1) |
|
Enzymatic Reactions of Wall-Deficient Tubercle Bacilli |
|
|
192 | (1) |
|
Wall Deficient Variants in Sputum and Other Specimens |
|
|
192 | (1) |
|
Incidence in Sputum and Significance |
|
|
192 | (1) |
|
Stained Smears of Exudate |
|
|
193 | (1) |
|
Concentration of CWD Colonies |
|
|
193 | (1) |
|
Disease from Only the CWD Stages |
|
|
193 | (1) |
|
Filtrable Stages of Mycobacterium tuberculosis |
|
|
194 | (1) |
|
Mycobacterium scrofulaceum |
|
|
195 | (1) |
|
Mycobacterium avium-intracellulaire (MAC Complex) |
|
|
195 | (1) |
|
|
196 | (1) |
|
|
196 | (1) |
|
Factors Fostering Mycobacterial Wall Deficiency |
|
|
197 | (1) |
|
``Fragility'' of CWD Mycobacteria |
|
|
197 | (1) |
|
|
197 | (1) |
|
|
197 | (4) |
|
|
|
Characteristics of the Disease |
|
|
201 | (1) |
|
|
201 | (1) |
|
|
201 | (1) |
|
Evidence Involving a Mycobacterium as Causative Agent |
|
|
201 | (6) |
|
|
201 | (1) |
|
|
201 | (1) |
|
Acid-Fast Organisms Sighted |
|
|
202 | (1) |
|
Evidence of a Transmissible Pathogen |
|
|
202 | (1) |
|
Culture of an Acid-Fast Organism |
|
|
203 | (1) |
|
Antibody vs. the Sarcoid Isolates |
|
|
204 | (1) |
|
Gel Electrophoresis of Protein Content |
|
|
204 | (1) |
|
|
204 | (2) |
|
|
206 | (1) |
|
Autofluorescence of Microcolonies |
|
|
206 | (1) |
|
Antimicrobial Sensitivity |
|
|
206 | (1) |
|
New Methods for Tuberculosis and Sarcoid Diagnosis |
|
|
207 | (1) |
|
Finding the Organism in the Blood |
|
|
207 | (1) |
|
|
207 | (1) |
|
|
207 | (1) |
|
|
207 | (1) |
|
|
208 | (3) |
|
|
|
|
211 | (1) |
|
In Vitro Growth of Mycobacterium leprae |
|
|
211 | (2) |
|
In Vivo Propagation of Mycobacterium leprae |
|
|
213 | (1) |
|
|
213 | (1) |
|
Leprosy in an Immunologically Deficient Animal |
|
|
213 | (1) |
|
|
213 | (1) |
|
Cell Cultures in Peritoneal Cavities |
|
|
214 | (1) |
|
A Stain for the Classical and Variant Stages of Mycobacterium leprae |
|
|
214 | (1) |
|
Analysis of Immune Complexes |
|
|
214 | (1) |
|
|
214 | (1) |
|
|
214 | (1) |
|
|
215 | (2) |
|
Crohn's Disease and Ulcerative Colitis |
|
|
|
|
217 | (3) |
|
Is CWD Pseudomonas maltophilia the Agent of CD? |
|
|
217 | (1) |
|
Is the CWD Form of Streptococcus fecalis Involved in These Inflammatory Bowel Diseases? |
|
|
218 | (1) |
|
Findings When Seeking Viruses |
|
|
218 | (1) |
|
Mycobacterial Involvement? Which One? |
|
|
218 | (1) |
|
Does Therapy Suggest Mycobacterial Involvement? |
|
|
219 | (1) |
|
|
220 | (1) |
|
|
221 | (4) |
|
Characteristics of Filtrable Forms |
|
|
|
|
225 | (1) |
|
Physical Characteristics of Filtrable Forms |
|
|
225 | (1) |
|
Stability and Resistance of the Filtrable Stage |
|
|
225 | (1) |
|
A Nonfiltrable L-Phase Organism |
|
|
225 | (1) |
|
Methods to Increase Filtrability |
|
|
226 | (1) |
|
Treatment to Release Filtrable Units |
|
|
226 | (1) |
|
Inhibitors and Increased Filtrability |
|
|
226 | (1) |
|
In Vivo vs. In Vitro Production of Filtrable Forms |
|
|
226 | (1) |
|
|
226 | (2) |
|
|
227 | (1) |
|
Membranes of Modified Cellulose |
|
|
228 | (1) |
|
Isolation and/or Reversion of Filtrable Forms |
|
|
228 | (2) |
|
Reversion of Filtrable Forms in Man |
|
|
228 | (1) |
|
Reversion of Filtrates in Laboratory Animals |
|
|
229 | (1) |
|
Isolations of Filtrable States from Man |
|
|
229 | (1) |
|
Filtrable Viruses May Not Be Filtrable Either |
|
|
230 | (1) |
|
|
230 | (1) |
|
|
230 | (5) |
|
|
|
|
235 | (1) |
|
Evidence that the Spirochetal Stage is Rare in Syphilis |
|
|
235 | (2) |
|
In Vitro Growth of Nontreponemal Stages |
|
|
237 | (2) |
|
Spinal Fluid as Culture Medium |
|
|
237 | (1) |
|
|
237 | (1) |
|
|
237 | (1) |
|
|
238 | (1) |
|
|
239 | (1) |
|
|
240 | (1) |
|
Yaws (Treponema pertenue) |
|
|
240 | (1) |
|
|
240 | (2) |
|
Spirochaeta myelophora in Multiple Sclerosis |
|
|
242 | (1) |
|
An L-Form Laboratory Looks at MS Specimens |
|
|
243 | (1) |
|
Lou Gehrig's Disease (ALS) |
|
|
243 | (1) |
|
|
243 | (1) |
|
|
244 | (1) |
|
Borrelia duttoni of African Relapsing Fever |
|
|
244 | (1) |
|
Borrelia recurrentis of European Relapsing Fever |
|
|
244 | (1) |
|
|
244 | (1) |
|
Growth Phases of a Borrelia from Bovine Rumen |
|
|
244 | (1) |
|
|
245 | (1) |
|
Leptospira icterohemorrhagiae |
|
|
245 | (1) |
|
|
246 | (1) |
|
Summary of the Spirochetal Growth Cycle |
|
|
246 | (1) |
|
|
247 | (4) |
|
|
|
|
251 | (2) |
|
|
251 | (1) |
|
|
251 | (1) |
|
|
252 | (1) |
|
|
253 | (1) |
|
Dermonecrotoxin of Corynebacterium hemolyticum |
|
|
253 | (1) |
|
|
253 | (1) |
|
Toxic Products from Vibrio |
|
|
253 | (1) |
|
Staphylococcal Enterotoxins |
|
|
253 | (1) |
|
|
254 | (1) |
|
Endotoxicity in Mice Made Hypersensitive by BCG |
|
|
254 | (1) |
|
Shwartzmann Reaction with Microbial L-Forms |
|
|
254 | (1) |
|
Lethality in Chick Embryo |
|
|
254 | (1) |
|
Endotoxins of Hemophilus and Bordetella |
|
|
254 | (1) |
|
Endotoxins of Pseudomonas aeruginosa |
|
|
255 | (1) |
|
|
255 | (1) |
|
|
255 | (1) |
|
|
255 | (2) |
|
|
|
Recognizing Wall Deficiency of Fungi |
|
|
257 | (1) |
|
|
257 | (1) |
|
Spontaneous Wall Deficient Variants In Vitro |
|
|
257 | (2) |
|
Natural Protoplasts of Histoplasma capsulatum |
|
|
257 | (1) |
|
Spontaneous Wall Deficient Saccharomyces and Candida |
|
|
257 | (1) |
|
Growth of Nutrient-Depleted Candida Cells |
|
|
258 | (1) |
|
Filtration to Demonstrate Spontaneously Wall Deficient Candida |
|
|
259 | (1) |
|
Pleomorphism after Injection into Plants |
|
|
259 | (1) |
|
Fungal Variants in Infections |
|
|
259 | (1) |
|
Mimicking of Tissue Cells by Fungal Wall-Free Variants |
|
|
260 | (1) |
|
Fluorescent Reagents and Polyacrylamide Gel to Identify Fungal Variants |
|
|
260 | (1) |
|
CWD Fungi Formed by Antibiotic, Dyes, or Enzymes |
|
|
261 | (2) |
|
Ramicidin, Mycostatin, Amphotericin B, Crystal Violet, and Brilliant Green |
|
|
261 | (1) |
|
|
262 | (1) |
|
Filtration of Candida Cultures Grown with Inhibitors |
|
|
262 | (1) |
|
Enzymes of the Snail, Helix pomatia |
|
|
262 | (1) |
|
Streptoenzyme from Streptomyces |
|
|
263 | (1) |
|
Enzyme from Mating Gametes |
|
|
263 | (1) |
|
|
263 | (1) |
|
Antibiotic-Dependent Gymnoplasts |
|
|
263 | (1) |
|
Variants as Research Tools |
|
|
264 | (1) |
|
|
265 | (1) |
|
|
265 | (4) |
|
Sensitivity to Antimicrobial Agents |
|
|
|
|
269 | (1) |
|
Sensitivity of CWD Variants from Infections |
|
|
269 | (1) |
|
Sensitivity of In Vitro-Produced Variants |
|
|
270 | (2) |
|
CWD Forms Inhibited by Cell Wall Inhibitors |
|
|
272 | (1) |
|
|
272 | (1) |
|
|
272 | (1) |
|
Findings with D-Cycloserine |
|
|
272 | (1) |
|
Reading Antibiotic Sensitivity Tests |
|
|
272 | (1) |
|
CWD Forms Resistant to Agents Lethal for Classical Organisms |
|
|
273 | (1) |
|
CWD Forms Inhibited by Agents Tolerated by the Classical Organism |
|
|
273 | (1) |
|
Revertants May Differ from Parents in Antibiotic Sensitivity |
|
|
273 | (1) |
|
Eradication of CWD Forms when Tissue Cultures are Contaminated |
|
|
274 | (1) |
|
|
275 | (1) |
|
|
275 | (4) |
|
Miscellaneous Disease and Malfunctions |
|
|
|
Lung and Bronchial Disease |
|
|
279 | (2) |
|
Historic Study with Streptobacillus moniliformis |
|
|
279 | (1) |
|
Pleurisy and Interstitial Lung Disease by CWD Forms from Uveitis |
|
|
279 | (1) |
|
Pneumonia Complicating a Kidney Graft |
|
|
280 | (1) |
|
Pneumococci Routinely Present in the Blood of Pneumonia Cases |
|
|
280 | (1) |
|
Hemophilus parainfluenzae |
|
|
281 | (1) |
|
L-Phase of Bordetella pertussis |
|
|
281 | (1) |
|
|
281 | (1) |
|
Pleurisy and Chronic Empyema |
|
|
281 | (1) |
|
|
281 | (2) |
|
|
283 | (1) |
|
|
283 | (1) |
|
|
284 | (1) |
|
Behcet's Syndrome and Canker Sores (Aphthous Ulcers) |
|
|
285 | (2) |
|
Specific Therapy in Behcet's Disease |
|
|
287 | (1) |
|
Canker Sores (Aphthous Ulcers) |
|
|
287 | (1) |
|
|
287 | (1) |
|
Neuroendocrine System Damage |
|
|
288 | (1) |
|
|
288 | (1) |
|
|
289 | (1) |
|
Systemic Lupus Erythermatosis |
|
|
289 | (1) |
|
|
289 | (1) |
|
|
289 | (1) |
|
|
289 | (1) |
|
|
290 | (5) |
|
|
|
Interactions of CWD Forms with Complete Phage |
|
|
295 | (1) |
|
|
295 | (1) |
|
Metabolism in Spheroplasts after Phage Invasion |
|
|
295 | (1) |
|
Phage Susceptibility and L-Phase Colony Type |
|
|
295 | (1) |
|
Revertability Related to Phage Adsorption |
|
|
295 | (1) |
|
Phage Type and Susceptibility to L-Phase Induction by Antibiotics |
|
|
296 | (1) |
|
Mechanism of Phage Release |
|
|
296 | (1) |
|
Sensitivity to Phage Acquired by Spheroplasting |
|
|
296 | (1) |
|
Comparative Yield of Free Phage from Parent and CWD Stages |
|
|
296 | (1) |
|
General Characteristics of Phage Related to the Ability to Attack CWD Variants |
|
|
296 | (1) |
|
|
296 | (3) |
|
Existence and Duration of Lysogeny in CWD Forms |
|
|
296 | (2) |
|
Production of Virulent Phage from Lysogenic CWD Forms |
|
|
298 | (1) |
|
Lysogeny Represses or Fosters Spheroplastic Tendencies |
|
|
298 | (1) |
|
In Vivo Associations of Phage and Host Microbe |
|
|
299 | (1) |
|
Susceptibility of Protoplasts to Phage |
|
|
299 | (1) |
|
Spheroplasts as Hosts for Phage Nucleic Acids |
|
|
299 | (1) |
|
|
299 | (1) |
|
Spheroplasts Interpret DNA and Repair Breaks in Nucleic Acids |
|
|
300 | (1) |
|
DNA Replication in Spheroplasts |
|
|
300 | (1) |
|
Phage RNA Reaction with a Psychotropic Drug |
|
|
300 | (1) |
|
Formation of CWD Cells by Phage |
|
|
300 | (1) |
|
Phage Penetrates Classical Organism |
|
|
300 | (1) |
|
CWD Formation after Contact with Inactivated Phage |
|
|
301 | (1) |
|
Phage-Associated Lysins (PAL) |
|
|
301 | (1) |
|
|
301 | (1) |
|
|
301 | (1) |
|
|
302 | (3) |
|
|
|
|
305 | (1) |
|
Relative Susceptibility of CWD Forms to Bacteriocins |
|
|
305 | (1) |
|
CWD Produced by Bacteriocins |
|
|
306 | (1) |
|
Bacteriocin Synthesis by CWD Forms |
|
|
306 | (1) |
|
Are Phage and Colicin Receptors Identical? |
|
|
306 | (2) |
|
|
308 | (1) |
|
|
308 | (3) |
|
|
|
Sterility from CWD Streptococci |
|
|
311 | (1) |
|
Legacy in Insects of Wall-Deficient Microbes |
|
|
311 | (3) |
|
Housing the Legacy in Colorful Mycetomes |
|
|
311 | (1) |
|
Mycetomes and their Content |
|
|
311 | (1) |
|
Symbionts Essential for Host Life |
|
|
311 | (1) |
|
Variation and Cycling in the Symbionts |
|
|
312 | (1) |
|
|
312 | (1) |
|
|
312 | (1) |
|
Culture of the Bacterial Symbionts |
|
|
313 | (1) |
|
Symbionts May Make N2 Available for Recycling by the Host |
|
|
314 | (1) |
|
Effects of Antibiotics on Symbionts |
|
|
314 | (1) |
|
Microbial Chef for the Leech |
|
|
314 | (1) |
|
|
315 | (1) |
|
|
315 | (2) |
|
|
|
|
317 | (1) |
|
|
317 | (1) |
|
|
317 | (1) |
|
|
318 | (1) |
|
Chalaropsis B Enzyme (An N-Acetyl Hexosaminidase) |
|
|
318 | (1) |
|
|
318 | (1) |
|
Phosphomannanase, An Enzyme from Bacillus circulans |
|
|
318 | (1) |
|
|
318 | (1) |
|
L-Forms Supporting Growth of a Ciliate |
|
|
318 | (1) |
|
|
318 | (1) |
|
|
319 | (1) |
|
|
319 | (1) |
|
Salt Content and Identification of Species |
|
|
319 | (1) |
|
Induction or Fostering by Unidentified Products of Microbial Growth |
|
|
319 | (1) |
|
Antibiotics Produced in Soil |
|
|
320 | (1) |
|
|
320 | (1) |
|
|
320 | (1) |
|
Alcaligenes L-Forms and Hepatitis Virus |
|
|
321 | (1) |
|
|
321 | (1) |
|
|
321 | (2) |
|
|
323 | (2) |
|
|
|
Beef Steak and Peanut Butter |
|
|
325 | (2) |
|
L-Forms and the Tobacco Industry |
|
|
326 | (1) |
|
Pathology of Plants Caused by CWD Bacteria |
|
|
327 | (1) |
|
Tumors in Bean and Carrot Plants |
|
|
327 | (1) |
|
|
327 | (1) |
|
Myriad Soil Bacteria Counted by Plating and Electron Microscopy |
|
|
327 | (3) |
|
Pour Plates Compared with Direct Microscopy |
|
|
327 | (1) |
|
Findings by Electron Microscopy |
|
|
327 | (1) |
|
L-Cycle of Azotobacter and Arthrobacter |
|
|
328 | (1) |
|
Gonidia Contrasted with the CWD Cycle |
|
|
328 | (1) |
|
Cores and Crystals in Streptomyces |
|
|
328 | (2) |
|
|
330 | (1) |
|
|
330 | (3) |
|
Microbes and Malignancies |
|
|
|
|
333 | (1) |
|
Etiology of Hodgkin's Disease |
|
|
333 | (1) |
|
|
334 | (1) |
|
Wall-Deficient Bacteria in Other Malignancies |
|
|
334 | (1) |
|
|
334 | (1) |
|
|
335 | (1) |
|
Classical Organisms which Produce Experimental Malignancies |
|
|
335 | (2) |
|
Bacteria and Fungi of Unknown Pathogenicity Found in Neoplasia |
|
|
337 | (1) |
|
How May a Bacterium Be Carcinogenic? |
|
|
337 | (1) |
|
Altering the Host's Antibody Response |
|
|
337 | (1) |
|
|
337 | (1) |
|
Does a Carcinogen-Fostering Bacterium Act as a Helper Virus? |
|
|
337 | (1) |
|
Does a Cancer Bacterium Work by In Vivo Synthesis of a Carcinogenic Compound? |
|
|
337 | (1) |
|
Do Carcinogen-Stimulating Bacteria Carry a Virus of Malignancy? |
|
|
337 | (1) |
|
Do Oncogenic Bacteria Flood the Host with Hormone-Like Substances? |
|
|
338 | (1) |
|
Inherent Difficulties in the Research |
|
|
338 | (1) |
|
Practical Application of Bacteria-in-Cancer Studies |
|
|
338 | (1) |
|
|
338 | (1) |
|
|
338 | (1) |
|
|
339 | (1) |
|
Diagnosis of Cancer by Serological Approach |
|
|
339 | (1) |
|
|
339 | (1) |
|
|
339 | (1) |
|
|
340 | (5) |
|
Artifacts and Contaminants |
|
|
|
|
345 | (1) |
|
|
346 | (1) |
|
|
347 | (2) |
|
|
|
|
349 | (1) |
|
|
350 | (1) |
|
Media, Methods, and Stains |
|
|
|
|
351 | (2) |
|
|
351 | (1) |
|
Rosner's Blood Culture Medium |
|
|
351 | (1) |
|
Domingue's Media for Isolation of CWD Forms from Blood or Urine |
|
|
352 | (1) |
|
|
352 | (1) |
|
Horse Muscle Infusion Medium |
|
|
353 | (1) |
|
Galactose-Containing Medium |
|
|
353 | (1) |
|
|
353 | (4) |
|
Penicillin Induction and Subculture of L-Forms of Staphylococci |
|
|
353 | (1) |
|
Gradient Plates for Induction or to Test Variables |
|
|
353 | (1) |
|
Semidefined Medium for Induction of Staphylococcus aureus L-Forms |
|
|
354 | (1) |
|
|
354 | (1) |
|
To Induce L-Forms from Streptococci |
|
|
354 | (1) |
|
Tryptic Digest of Cardiac Muscle |
|
|
354 | (1) |
|
To Induce L-Forms from Salmonella |
|
|
355 | (1) |
|
For Inducing L-Forms of Mycobacteria |
|
|
355 | (1) |
|
Induction of CWD Forms from Nocardia asteroides |
|
|
355 | (1) |
|
Medium to Produce Stable L-Forms of Clostridium perfringens |
|
|
356 | (1) |
|
Medium to Obtain L-Forms of Neisseria meningitidis |
|
|
356 | (1) |
|
Medium for Continued Propagation of CWD Forms |
|
|
357 | (2) |
|
Medium for Maintaining L-Forms of Staphylococcus aureus |
|
|
358 | (1) |
|
Medium for Maintenance of CWD Mycobacteria |
|
|
358 | (1) |
|
Caprice of Culture Media and of CWD Microbes |
|
|
359 | (2) |
|
|
359 | (1) |
|
|
359 | (1) |
|
Agar Source and Concentration |
|
|
359 | (1) |
|
|
360 | (1) |
|
|
360 | (1) |
|
Changes in the Same Medium |
|
|
360 | (1) |
|
|
360 | (1) |
|
|
360 | (1) |
|
|
361 | (1) |
|
Osmotic Stabilizers and Adjusting to Normal Osmolality |
|
|
361 | (2) |
|
|
362 | (1) |
|
|
362 | (1) |
|
Inorganic Salts in Stabilizing |
|
|
362 | (1) |
|
Hypertonicity from Carbohydrates |
|
|
362 | (1) |
|
Adaptation of CWD Staphylococcus aureus to Normal Osmolality |
|
|
362 | (1) |
|
|
363 | (1) |
|
Yeast Extracts: Sources, ``Sterilizing,'' and Content |
|
|
364 | (1) |
|
Amino Acid Requirements for Nutrition |
|
|
364 | (1) |
|
Media Components that Inhibit CWD Variants |
|
|
365 | (1) |
|
|
365 | (1) |
|
|
365 | (1) |
|
Ogawa Medium for Mycobacteria |
|
|
365 | (1) |
|
|
366 | (1) |
|
Concentrating Organisms from a Broth Culture |
|
|
366 | (1) |
|
Concentrating Borrelia from Lyme, Multiple Sclerosis, and ALS |
|
|
366 | (1) |
|
|
366 | (1) |
|
Pour Plates of Distilled or Deionized Water |
|
|
366 | (1) |
|
Preparations for Electron Microscopy |
|
|
366 | (1) |
|
|
367 | (5) |
|
Fixation and Washing Smears |
|
|
367 | (1) |
|
|
367 | (1) |
|
Procedure for Acridine Orange Stain |
|
|
367 | (1) |
|
Acridine Orange Acid-Fast Stain |
|
|
367 | (1) |
|
|
368 | (1) |
|
Rhodamine B-Labeled Muramidase |
|
|
368 | (1) |
|
Dienes' Stain for Impression Smears |
|
|
369 | (1) |
|
Vital Staining of L-Forms with Chlorazol Black E |
|
|
370 | (1) |
|
Kinyoun's Stain: Intensified for Detection of Acid-Fast CWD Forms |
|
|
370 | (1) |
|
Metanil Yellow Counter Stain |
|
|
371 | (1) |
|
Periodic Acid Pretreatment |
|
|
371 | (1) |
|
Auramine-Rhodamine (AR) Fluorescent Stain for Mycobacteria |
|
|
371 | (1) |
|
Victoria Blue Acid-Fast Stain for Classical and CWD Mycobacteria |
|
|
371 | (1) |
|
|
371 | (1) |
|
Composition of Stain, Decolorizer, and Counterstain |
|
|
371 | (1) |
|
|
372 | (1) |
|
|
372 | (1) |
|
|
372 | (7) |
|
|
|
|
379 | (1) |
|
|
379 | (1) |
|
Biochemical Reactions and Unique Components |
|
|
379 | (3) |
|
Reactions with Analytab Substrates |
|
|
379 | (1) |
|
|
380 | (1) |
|
|
380 | (1) |
|
|
381 | (1) |
|
|
381 | (1) |
|
|
381 | (1) |
|
|
382 | (1) |
|
|
382 | (1) |
|
|
382 | (1) |
|
Triphenyltetrazolium Chloride (TTC) Reactions |
|
|
382 | (1) |
|
Tellurite Reduction Medium |
|
|
383 | (1) |
|
|
383 | (1) |
|
|
383 | (1) |
|
|
384 | (1) |
|
M Protein and Hyaluronic Acid from β-Hemolytic Strep |
|
|
384 | (1) |
|
Agglutination and Hemagglutination |
|
|
384 | (1) |
|
|
385 | (1) |
|
|
385 | (1) |
|
|
386 | (2) |
|
Growth Readings Suggest CWD Organisms |
|
|
388 | (1) |
|
Bacteriocins and Bacteriophage |
|
|
388 | (1) |
|
|
388 | (1) |
|
|
388 | (1) |
|
|
388 | (1) |
|
Immunoassay and Radioimmunoassay |
|
|
388 | (1) |
|
Nucleic Acid Probes and Hybridization |
|
|
389 | (1) |
|
Gas Chromatography-Mass Spectroscopy |
|
|
389 | (1) |
|
|
389 | (1) |
|
Antibody Sensitivity Testing |
|
|
390 | (1) |
|
Electron Microscopy with Antibody |
|
|
390 | (1) |
|
|
390 | (1) |
|
|
391 | (1) |
|
|
391 | (4) |
Appendix |
|
395 | (2) |
Author Index |
|
397 | (8) |
Subject Index |
|
405 | |